‘A Fine Mess We’re In’: Majority of Cancer Preclinical Research Findings Not Replicable
Alll that researcher time, and government and private investor money? Seems study after study is no good, even after it receives the gold-medal treatment in premeir journals. It’s a fine mess we’re in, if we’re relying on cancer labs to come up with new cures for very serious illnesses.